Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Farzahna Mohamed

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
BMJ (Clinical Research Ed.)|November 23, 2019
A pain in the neckFarzahna Mohamed, Frederick Raal
The Lancet. Global Health|February 18, 2022
Statins: are they appropriate for all patients?Frederick J Raal, Farzahna Mohamed
The New England Journal of Medicine|May 5, 2021
Hyperpigmentation from Addison's DiseaseFarzahna Mohamed, Frederick J Raal
The Lancet. Diabetes & Endocrinology|July 6, 2019
More aggressive lipid lowering in people with diabetes?Frederick J Raal, Farzahna Mohamed
Nature Reviews. Cardiology|March 11, 2026
ANGPTL3-lowering strategies to address residual cardiovascular riskFarzahna Mohamed, Frederick J Raal
Lancet (London, England)|November 13, 2020
Never too old to benefit from lipid-lowering treatmentFrederick J Raal, Farzahna Mohamed
Clinical Chemistry|April 28, 2023
Severe Hypophosphatemia: The Hidden TruthFarzahna Mohamed, Frederick J Raal
JCEM Case Reports|January 29, 2024
Unraveling the Whipple Triad: Non-Islet Cell Tumor-Induced HypoglycemiaFarzahna Mohamed, Frederick J Raal
Current Opinion in Endocrinology, Diabetes, and Obesity|December 5, 2020
Novel therapies for familial hypercholesterolemiaFarzahna Mohamed, Faheem Seedat, Frederick J Raal
Journal of Clinical Medicine|August 12, 2023
Targeting PCSK9 and Beyond for the Management of Low-Density Lipoprotein CholesterolFarzahna Mohamed, Brett Mansfield, Frederick J Raal
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
BMJ (Clinical Research Ed.)|November 23, 2019
A pain in the neckFarzahna Mohamed, Frederick Raal
The Lancet. Global Health|February 18, 2022
Statins: are they appropriate for all patients?Frederick J Raal, Farzahna Mohamed
The New England Journal of Medicine|May 5, 2021
Hyperpigmentation from Addison's DiseaseFarzahna Mohamed, Frederick J Raal
The Lancet. Diabetes & Endocrinology|July 6, 2019
More aggressive lipid lowering in people with diabetes?Frederick J Raal, Farzahna Mohamed
Nature Reviews. Cardiology|March 11, 2026
ANGPTL3-lowering strategies to address residual cardiovascular riskFarzahna Mohamed, Frederick J Raal
Lancet (London, England)|November 13, 2020
Never too old to benefit from lipid-lowering treatmentFrederick J Raal, Farzahna Mohamed
Clinical Chemistry|April 28, 2023
Severe Hypophosphatemia: The Hidden TruthFarzahna Mohamed, Frederick J Raal
JCEM Case Reports|January 29, 2024
Unraveling the Whipple Triad: Non-Islet Cell Tumor-Induced HypoglycemiaFarzahna Mohamed, Frederick J Raal
Current Opinion in Endocrinology, Diabetes, and Obesity|December 5, 2020
Novel therapies for familial hypercholesterolemiaFarzahna Mohamed, Faheem Seedat, Frederick J Raal
Journal of Clinical Medicine|August 12, 2023
Targeting PCSK9 and Beyond for the Management of Low-Density Lipoprotein CholesterolFarzahna Mohamed, Brett Mansfield, Frederick J Raal
Pageof 3